羊膜製品の世界市場予測:タイプ別[羊膜(凍結保存羊膜、脱水羊膜)、羊水懸濁液]、用途別(創傷ケア、眼科、整形外科)、エンドユーザー別(病院、ASC)

◆英語タイトル:Amniotic Products Market by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions], Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospital, ASCs) - Global Forecast to 2025
◆商品コード:MD 7637
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:127
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は羊膜製品の世界市場が2020年7億4800万ドルから2025年10億9500万ドルまで、年平均7.9%成長すると予測しています。本調査レポートでは、羊膜製品の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(羊膜、羊水懸濁液)、用途別(創傷ケア、整形外科、眼科、その他)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・羊膜製品の世界市場:種類別(羊膜、羊水懸濁液)
・羊膜製品の世界市場:用途別(創傷ケア、整形外科、眼科、その他)
・羊膜製品の世界市場:地域別
・競争状況
・企業概要
【レポートの概要】

“Growth in the target patient population and awareness programs for wound care treatment and management are expected to drive the overall growth of the amniotic products market.”
The global amniotic products market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%. Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments. The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.

“The cryopreserved amniotic membranes segment is expected to dominate the market during the forecast period.”
On the basis of type, amniotic membranes are categorized into cryopreserved amniotic membranes and dehydrated amniotic membranes. Both membrane types come in a variety of tissue thicknesses and sizes, depending on clinical needs. Cryopreserved amniotic membranes commanded the largest share of the global amniotic membranes market in 2019. The cryopreservation technique retains extracellular matrix components, such as growth factors, collagen, heavy-chain hyaluronic acids, and fibronectin, all of which promote anti-inflammatory effects and healing. These characteristics of cryopreserved amniotic membranes drive market growth.

“Wound care application segment to witness the highest growth in the amniotic products market during the forecast period.”
Based on application, the amniotic products market is categorized into wound care, ophthalmology, orthopedics, and other applications. Wound care was the largest application segment in the amniotic products market in 2019 and is expected to grow at the highest CAGR during the forecast period. Growth in this market is largely driven by the rising prevalence of diabetic foot ulcers, venous leg ulcers, surgical & traumatic wounds, and burn injuries.

“North America to dominate the market during the forecast period.”
Geographically, the amniotic products market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the amniotic products market. The large share of this region can be attributed to the increasing geriatric population, the strong presence of key market players of amniotic products, the high prevalence of target diseases, and rising awareness about advanced treatment options.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (36%), Tier 2 (45%), and Tier 3 (19%)
• By Designation: C-level (33%), Directors (40%), and Others (27%)
• By Region: North America (36%), Europe (28%), Asia Pacific (19%), and the Rest of the World (17%)

List of Companies Profiled in the Report
• MiMedx (US)
• Smith & Nephew (UK)
• Organogenesis (US)
• Integra LifeSciences Corporation (US)
• Stryker Corporation (US)
• Wright Medical (Netherlands)
• Applied Biologics (US)
• Celularity (US)
• Katena Products (US)
• Lucina BioSciences (US)
• Next Biosciences (South Africa)
• Skye Biologics (US)
• Surgenex (US)
• TissueTech (US)
• Ventris Medical (US)
• StimLabs (US)
• VIVEX Biologics (US)
• LifeCell International (India)
• NuVision Biotherapies (England)
• Genesis Biologics (US)

Research Coverage:
This report provides a detailed picture of the global amniotic products market. It aims at estimating the size and future growth potential of the market across different segments, such as type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall amniotic products market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights in order to position their businesses better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 15)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 18)
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 25)

4 PREMIUM INSIGHTS (Page No. – 29)
4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
4.2 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
4.3 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
4.4 AMNIOTIC PRODUCTS MARKET, BY END USER, 2019
4.5 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. – 32)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the target patient population
5.2.1.2 Rising incidence of burn injuries
5.2.1.3 Awareness programs for wound care treatment and management
5.2.1.4 Rise in venture capital investment and government funding
5.2.2 OPPORTUNITIES
5.2.2.1 Emerging economies
5.2.2.2 Implementation of the 21st Century Cures Act (US)
5.2.3 CHALLENGES
5.2.3.1 Complications and limitations associated with the use of amniotic membranes

6 AMNIOTIC PRODUCTS MARKET, BY TYPE (Page No. – 38)
6.1 INTRODUCTION
6.2 AMNIOTIC MEMBRANES
6.2.1 CRYOPRESERVED AMNIOTIC MEMBRANES
6.2.1.1 Cryopreserved amniotic membranes to dominate the market during the forecast period
6.2.2 DEHYDRATED AMNIOTIC MEMBRANES
6.2.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
6.3 AMNIOTIC SUSPENSIONS
6.3.1 ANTI-ADHESIVE, ANTI-INFLAMMATORY, AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE GROWTH

7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION (Page No. – 47)
7.1 INTRODUCTION
7.2 WOUND CARE
7.2.1 WOUND CARE APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE AMNIOTIC PRODUCTS MARKET
7.3 ORTHOPEDICS
7.3.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
7.4 OPHTHALMOLOGY
7.4.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
7.5 OTHER APPLICATIONS

8 AMNIOTIC PRODUCTS MARKET, BY REGION (Page No. – 56)
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 The US to dominate the North American amniotic products market during the forecast period
8.2.2 CANADA
8.2.2.1 Rising prevalence of target diseases to drive market growth
8.3 EUROPE
8.3.1 UK
8.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2019
8.3.2 GERMANY
8.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
8.3.3 FRANCE
8.3.3.1 Rising government support to drive the market demand for amniotic products in France
8.3.4 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.1.1 China to dominate the Asia Pacific market during the forecast period
8.4.2 JAPAN
8.4.2.1 Growing geriatric population to drive market growth in Japan
8.4.3 ROAPAC
8.5 ROW

9 COMPETITIVE LANDSCAPE (Page No. – 85)
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS, 2018
9.3 COMPETITIVE SCENARIO
9.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.3.2 PRODUCT LAUNCHES & APPROVALS
9.3.3 EXPANSIONS
9.3.4 ACQUISITIONS
9.4 COMPETITIVE LEADERSHIP MAPPING (2019)
9.4.1 VENDOR INCLUSION CRITERIA
9.4.2 VISIONARY LEADERS
9.4.3 INNOVATORS
9.4.4 DYNAMIC DIFFERENTIATORS
9.4.5 EMERGING COMPANIES

10 COMPANY PROFILES (Page No. – 93)
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 MIMEDX
10.2 SMITH & NEPHEW
10.3 ORGANOGENESIS INC.
10.4 INTEGRA LIFESCIENCES CORPORATION
10.5 STRYKER CORPORATION
10.6 WRIGHT MEDICAL GROUP
10.7 APPLIED BIOLOGICS
10.8 CELULARITY, INC.
10.9 KATENA PRODUCTS, INC.
10.10 LUCINA BIOSCIENCES
10.11 NEXT BIOSCIENCES
10.12 SKYE BIOLOGICS INC.
10.13 SURGENEX
10.14 TISSUETECH, INC.
10.15 VENTRIS MEDICAL, LLC
10.16 STIMLABS LLC
10.17 VIVEX BIOLOGICS, INC.
10.18 LIFECELL INTERNATIONAL PVT. LTD.
10.19 NUVISION BIOTHERAPIES LIMITED
10.20 GENESIS BIOLOGICS
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[羊膜製品の世界市場予測:タイプ別[羊膜(凍結保存羊膜、脱水羊膜)、羊水懸濁液]、用途別(創傷ケア、眼科、整形外科)、エンドユーザー別(病院、ASC)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆